Dewpoint Therapeutics

The discovery of biomolecular #condensates was an astounding breakthrough. A revelation so profound, it completely transformed the understanding of cellular function and organization. Discover how Dewpoint is exploring the relationship between condensate biology and human disease to advance therapies for diseases previously thought undruggable. https://lnkd.in/expN2ZSR #DiscoverDewpoint #biotechnology

At our Harvest of Cultures event, our Boston team took time to give thanks and celebrate our diversity, families and friends, and each other! Team members shared special dishes that showcased their unique backgrounds, had fun together playing games, and strengthened our amazing Dewpoint community!  

👨🔬 🗺️ 💪 Teamwork makes the dream work! It was an honor to welcome our colleagues at Bayer | Pharmaceuticals to our site in Boston to meet with our team and tour our state-of-the-art drug discovery facilities. We enjoyed the engaging discussions on how we can apply the power of #condensate science to push the boundaries of what is possible and together develop lifesaving therapeutics 🧬 💊 🔬.  

Over a century ago, a groundbreaking discovery in a lab at the University of Toronto changed the course of diabetes care. The introduction of insulin not only transformed the lives of millions worldwide, but also paved the way for a series of breakthroughs in managing diabetes symptoms. On #WorldDiabetesDay and every day, our commitment drives us to create and deliver transformative solutions for individuals impacted by diabetes. As we think through the next chapter of innovation in diabetes treatment, the connectivity between academia and industry remains pivotal, especially as we focus on digging deeper into disease biology and pioneering novel therapeutic approaches to stop or even reverse disease progression. Collaborating with partners like Dewpoint Therapeutics, the Whitehead Institute, and the Broad Institute of MIT and Harvard fuels our pursuit of new frontiers in diabetes care.

We are excited to partner with Condensates at Membrane Scaffolds - Synthetic Cell Compartments (#ComeInCell) doctoral network to support future biomedical and biotechnology researchers by providing scientific expertise in biomolecular #condensates and mentorship as they explore cellular mechanisms with advanced synthetic models.  Learn more about the investigators, projects and opportunities to join this network as a trainee here: https://lnkd.in/e5FnqgWK

Thank you Dragomir Milovanovic for the engaging discussion about condensate biology at the synapse at our Kitchen Table Talk last week! If you missed the live event, the video recording is now available on condensates.com. View it here: https://lnkd.in/gyDfsy-6

🎃 It’s a Dewpoint Halloween! Check out the spooky fun our Boston team had with creative costumes, a blind candy taste test, pumpkin decoupage decorating, and even making their own “potions”! #HappyHalloween #SpookySeason

Great coverage in The Pharma Letter about a major milestone for Dewpoint – the nomination of our first development candidate, DPTX3186, as a potential therapeutic agent for the treatment of Wnt-driven cancers. Read the article: https://lnkd.in/g5S33rWM.